Determination of Chemical Composition and α-amylase Inhibitory Effect of New Propolis Extracts

dc.authoridKeskin, Merve/0000-0001-9365-334X
dc.contributor.authorKeskin, Merve
dc.date.accessioned2025-05-20T18:54:09Z
dc.date.issued2020
dc.departmentBilecik Şeyh Edebali Üniversitesi
dc.description.abstractBackground: Propolis is a resinous mixture collected by honeybees from tree buds and exudates of the plants. Propolis contains aromatic acids, diterpenic acids and phenolic compounds and these components are responsible for its antitumor, anticancer, antiviral and antifungal effects. Propolis can be extracted and the solubility of propolis differs depending on the solvent used in the process of extraction. Solvents used for propolis extraction have a great impact on the propolis extract and should be nontoxic. Objective: In this study, raw propolis was extracted by peppermint and clove volatile oils. Methods: Chemical composition of extracts was determined by using GC-MS equipment. Total phenolic content and antioxidant activity of the extracts were measured. a-amylase inhibitory activity of the extracts was carried out as well. Results: The findings of the present study showed that clove volatile oil is more effective in the extraction of propolis than peppermint volatile oil. The total phenolic content of these extracts was determined as 175.12 and 40.80 mg GAE/mL for clove and peppermint oil propolis extracts, respectively. All extracts contained the same phenolic compounds but the quantity was less in volatile oil extract than in ethanol extract. Both of these extracts showed better a-amylase mhibitory activity than a reference inhibitor, acarbose. Conclusion: It could be concluded that propolis extract obtained by using volatile oils could be used as a complementary agent in the treatment of type 2 diabetes mellitus.
dc.identifier.doi10.2174/1386207323666200402080557
dc.identifier.endpage944
dc.identifier.issn1386-2073
dc.identifier.issn1875-5402
dc.identifier.issue9
dc.identifier.pmid32238136
dc.identifier.scopus2-s2.0-85096667094
dc.identifier.scopusqualityQ3
dc.identifier.startpage939
dc.identifier.urihttps://doi.org/10.2174/1386207323666200402080557
dc.identifier.urihttps://hdl.handle.net/11552/7254
dc.identifier.volume23
dc.identifier.wosWOS:000601304400012
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWoS
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakWoS - Science Citation Index Expanded
dc.institutionauthorKeskin, Merve
dc.language.isoen
dc.publisherBentham Science Publ Ltd
dc.relation.ispartofCombinatorial Chemistry & High Throughput Screening
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250518
dc.subjectPropolis
dc.subjectvolatile oils
dc.subjectextraction
dc.subjectphenolic compounds
dc.subjectalpha-amylase inhibition
dc.subjecttype 2 diabetes mellitus
dc.titleDetermination of Chemical Composition and α-amylase Inhibitory Effect of New Propolis Extracts
dc.typeArticle

Dosyalar